Citations (40)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Chiara Ferraris, Roberta Cavalli, Pier Paolo Panciani & Luigi Battaglia. (2020) Overcoming the Blood–Brain Barrier: Successes and Challenges in Developing Nanoparticle-Mediated Drug Delivery Systems for the Treatment of Brain Tumours. International Journal of Nanomedicine 15, pages 2999-3022.
Read now
Read now
Maria B. Garcia-Fabiani, Maria Ventosa, Andrea Comba, Marianela Candolfi, Alejandro J. Nicola Candia, Mahmoud S. Alghamri, Padma Kadiyala, Stephen Carney, Syed M. Faisal, Anna Schwendeman, James J. Moon, Lindsay Scheetz, Joerg Lahann, Ava Mauser, Pedro R. Lowenstein & Maria G. Castro. (2020) Immunotherapy for gliomas: shedding light on progress in preclinical and clinical development. Expert Opinion on Investigational Drugs 29:7, pages 659-684.
Read now
Read now
Articles from other publishers (38)
Dasun Fernando, Afsar U. Ahmed & Bryan R. G. Williams. (2024) Therapeutically targeting the unique disease landscape of pediatric high-grade gliomas. Frontiers in Oncology 14.
Crossref
Crossref
Stefaan W. Van Gool, Peter Van de Vliet, Linde F.C. Kampers, Jennifer Kosmal, Tobias Sprenger, Ella Reich, Volker Schirrmacher & Wilfried Stuecker. 2024. Cell-based Cancer Immunotherapy. Cell-based Cancer Immunotherapy
51
113
.
Robert C. Subtirelu, Eric M. Teichner, Arjun Ashok, Chitra Parikh, Sahithi Talasila, Irina-Mihaela Matache, Ahab G. Alnemri, Victoria Anderson, Osmaan Shahid, Sricharvi Mannam, Andrew Lee, Thomas Werner, Mona-Elisabeth Revheim & Abass Alavi. (2023) Advancements in dendritic cell vaccination: enhancing efficacy and optimizing combinatorial strategies for the treatment of glioblastoma. Frontiers in Neurology 14.
Crossref
Crossref
Shuyun Lin, Kaishu Li & Ling Qi. (2023) Cancer stem cells in brain tumors: From origin to clinical implications. MedComm 4:4.
Crossref
Crossref
Berta Segura-Collar, Sara Hiller-Vallina, Olaya de Dios, Marta Caamaño-Moreno, Lucia Mondejar-Ruescas, Juan M. Sepulveda-Sanchez & Ricardo Gargini. (2023) Advanced immunotherapies for glioblastoma: tumor neoantigen vaccines in combination with immunomodulators. Acta Neuropathologica Communications 11:1.
Crossref
Crossref
Hamed Hosseinalizadeh, Mohammad Rahmati, Ammar Ebrahimi & Roddy S. O'Connor. (2023) Current Status and Challenges of Vaccination Therapy for Glioblastoma. Molecular Cancer Therapeutics 22:4, pages 435-446.
Crossref
Crossref
Muhammad Reza Arifianto, Rizki Meizikri, Irwan Barlian Immadoel Haq, Rahadian Indarto Susilo, Joni Wahyuhadi, Yulius Hermanto & Ahmad Faried. (2023) Emerging hallmark of gliomas microenvironment in evading immunity: a basic concept. The Egyptian Journal of Neurology, Psychiatry and Neurosurgery 59:1.
Crossref
Crossref
Jing Zhou, Luohong Li, Minqi Jia, Qianjin Liao, Guiping Peng, Gengqiu Luo & Yanhong Zhou. (2022) Dendritic cell vaccines improve the glioma microenvironment: Influence, challenges, and future directions. Cancer Medicine 12:6, pages 7207-7221.
Crossref
Crossref
Rita Cascão & Claudia C. Faria. 2023. New Insights Into Glioblastoma. New Insights Into Glioblastoma
553
591
.
Juan Esteban Garcia-Robledo, Oscar Arrieta, Camila Ordoñez, Andrés Mosquera & Andrés F. Cardona. 2023. New Insights Into Glioblastoma. New Insights Into Glioblastoma
515
538
.
Mohamed Abdul-Al, Morvarid Saeinasab, Adriana Zare, Masoumeh Barati, Shahryar Shakeri, Ehsan Keykhosravi, Madjid Momeni-Moghaddam, Mojgan Najafzadeh, Saeed Heidari Keshel, Gholamali Farzi & Farshid Sefat. (2022) Application of biomaterials for glioblastoma treatment: Promises, advances, and challenges. Materials Today Communications 33, pages 104562.
Crossref
Crossref
Gianni Monaco, Ashkan Khavaran, Adrià Dalmau Gasull, Jonathan Cahueau, Martin Diebold, Chintan Chhatbar, Mirco Friedrich, Dieter Henrik Heiland & Roman Sankowski. (2022) Transcriptome Analysis Identifies Accumulation of Natural Killer Cells with Enhanced Lymphotoxin-β Expression during Glioblastoma Progression. Cancers 14:19, pages 4915.
Crossref
Crossref
Mohsen Karami Fath, Kimiya Babakhaniyan, Mehran Anjomrooz, Mohammadrasoul Jalalifar, Seyed Danial Alizadeh, Zeinab Pourghasem, Parisa Abbasi Oshagh, Ali Azargoonjahromi, Faezeh Almasi, Hafza Zahira Manzoor, Bahman Khalesi, Navid Pourzardosht, Saeed Khalili & Zahra Payandeh. (2022) Recent Advances in Glioma Cancer Treatment: Conventional and Epigenetic Realms. Vaccines 10:9, pages 1448.
Crossref
Crossref
D. J. McMahon, J. P. Gleeson, S. O’Reilly & R. M. Bambury. (2022) Management of newly diagnosed glioblastoma multiforme: current state of the art and emerging therapeutic approaches. Medical Oncology 39:9.
Crossref
Crossref
Amandeep Thakur, Chetna Faujdar, Ram Sharma, Sachin Sharma, Basant Malik, Kunal Nepali & Jing Ping Liou. (2022) Glioblastoma: Current Status, Emerging Targets, and Recent Advances. Journal of Medicinal Chemistry 65:13, pages 8596-8685.
Crossref
Crossref
Lina Nguyen, Catherine Christie, Steen J. Madsen, Qian Peng, Kristian Berg & Henry Hirschberg. (2022) Inhibition of glioma development by doxorubicin-photochemical internalization generated macrophage vaccine: A survival study in rats. Photodiagnosis and Photodynamic Therapy 38, pages 102879.
Crossref
Crossref
Nélio A.J. Oliveira & Handan Sevim. (2022) Dendritic Cell Differentiation from Human Induced Pluripotent Stem Cells: Challenges and Progress. Stem Cells and Development 31:9-10, pages 207-220.
Crossref
Crossref
Stefaan W. Van Gool, Jennifer Makalowski, Michael Bitar, Peter Van de Vliet, Volker Schirrmacher & Wilfried Stuecker. (2022) Synergy between TMZ and individualized multimodal immunotherapy to improve overall survival of IDH1 wild-type MGMT promoter-unmethylated GBM patients. Genes & Immunity 23:8, pages 255-259.
Crossref
Crossref
Keyang Yang, Zhijing Wu, Hao Zhang, Nan Zhang, Wantao Wu, Zeyu Wang, Ziyu Dai, Xun Zhang, Liyang Zhang, Yun Peng, Weijie Ye, Wenjing Zeng, Zhixiong Liu & Quan Cheng. (2022) Glioma targeted therapy: insight into future of molecular approaches. Molecular Cancer 21:1.
Crossref
Crossref
I.S. Dolgopolov, M.Yu. Rykov, G.L. Mentkevich, G.Z. Chkadua & M.V. Ryzhova. (2022) Immunotherapy for a patient with high-grade glioblastoma. Onkologiya. Zhurnal imeni P.A.Gertsena 11:6, pages 37.
Crossref
Crossref
Myung-Hoon Han & Choong Hyun Kim. (2022) Current Immunotherapeutic Approaches for Malignant Gliomas. Brain Tumor Research and Treatment 10:1, pages 1.
Crossref
Crossref
Pavlina Chuntova, Payal B. Watchmaker, Ryan Gilbert & Hideho Okada. 2022. Immunotherapeutic Strategies for the Treatment of Glioma. Immunotherapeutic Strategies for the Treatment of Glioma
109
125
.
Leila A. Mashouf, Janet Y. Wu, Pavan Shah, Nivedha Kannapadi & Michael Lim. (2021) Applying Synthetic Biology with Rational Design to Nature’s Greatest Challenges: Bioengineering Immunotherapeutics for the Treatment of Glioblastoma. Immuno 2:1, pages 40-51.
Crossref
Crossref
Yan Li, Yiqi Ma, Zijun Wu, Ruoxi Xie, Fanxin Zeng, Huawei Cai, Su Lui, Bin Song, Lei Chen & Min Wu. (2021) Advanced Imaging Techniques for Differentiating Pseudoprogression and Tumor Recurrence After Immunotherapy for Glioblastoma. Frontiers in Immunology 12.
Crossref
Crossref
Mahmoud S. Alghamri, Brandon L. McClellan, Carson S. Hartlage, Santiago Haase, Syed Mohd Faisal, Rohit Thalla, Ali Dabaja, Kaushik Banerjee, Stephen V. Carney, Anzar A. Mujeeb, Michael R. Olin, James J. Moon, Anna Schwendeman, Pedro R. Lowenstein & Maria G. Castro. (2021) Targeting Neuroinflammation in Brain Cancer: Uncovering Mechanisms, Pharmacological Targets, and Neuropharmaceutical Developments. Frontiers in Pharmacology 12.
Crossref
Crossref
Amrita Basu, Ganesan Ramamoorthi, Gabriella Albert, Corey Gallen, Amber Beyer, Colin Snyder, Gary Koski, Mary L. Disis, Brian J. Czerniecki & Krithika Kodumudi. (2021) Differentiation and Regulation of TH Cells: A Balancing Act for Cancer Immunotherapy. Frontiers in Immunology 12.
Crossref
Crossref
Vianney Gilard, Abdellah Tebani, Ivana Dabaj, Annie Laquerrière, Maxime Fontanilles, Stéphane Derrey, Stéphane Marret & Soumeya Bekri. (2021) Diagnosis and Management of Glioblastoma: A Comprehensive Perspective. Journal of Personalized Medicine 11:4, pages 258.
Crossref
Crossref
Deyu Zhang, Xiaojie Xu & Qinong Ye. (2020) Metabolism and immunity in breast cancer. Frontiers of Medicine 15:2, pages 178-207.
Crossref
Crossref
Keenan Piper, Lisa DePledge, Michael Karsy & Charles Cobbs. (2021) Glioma Stem Cells as Immunotherapeutic Targets: Advancements and Challenges. Frontiers in Oncology 11.
Crossref
Crossref
Anna Borgenvik, Matko Čančer, Sonja Hutter & Fredrik J. Swartling. (2021) Targeting MYCN in Molecularly Defined Malignant Brain Tumors. Frontiers in Oncology 10.
Crossref
Crossref
Catalina Lee-Chang, Jason Miska, David Hou, Aida Rashidi, Peng Zhang, Rachel A. Burga, Ignacio Jusué-Torres, Ting Xiao, Victor A. Arrieta, Daniel Y. Zhang, Aurora Lopez-Rosas, Yu Han, Adam M. Sonabend, Craig M. Horbinski, Roger Stupp, Irina V. Balyasnikova & Maciej S. Lesniak. (2021) Activation of 4-1BBL+ B cells with CD40 agonism and IFNγ elicits potent immunity against glioblastoma. Journal of Experimental Medicine 218:1.
Crossref
Crossref
Eilam Yeini, Paula Ofek, Nitzan Albeck, Daniel Rodriguez Ajamil, Lena Neufeld, Anat Eldar‐Boock, Ron Kleiner, Daniella Vaskovich, Shani Koshrovski‐Michael, Sahar Israeli Dangoor, Adva Krivitsky, Christian Burgos Luna, Gal Shenbach‐Koltin, Miki Goldenfeld, Ori Hadad, Galia Tiram & Ronit Satchi‐Fainaro. (2020) Targeting Glioblastoma: Advances in Drug Delivery and Novel Therapeutic Approaches. Advanced Therapeutics 4:1.
Crossref
Crossref
Fleury Augustin Nsole Biteghe, Nyangone Ekome Toung Chalomie, Neelakshi Mungra, Guillaume Vignaux, Nan Gao, Aurelia Vergeade, Ambrose Okem, Krupa Naran, Jean De La Croix Ndong & Stefan Barth. (2020) Antibody-Based Immunotherapy: Alternative Approaches for the Treatment of Metastatic Melanoma. Biomedicines 8:9, pages 327.
Crossref
Crossref
Shengchao Xu, Lu Tang, Xizhe Li, Fan Fan & Zhixiong Liu. (2020) Immunotherapy for glioma: Current management and future application. Cancer Letters 476, pages 1-12.
Crossref
Crossref
Darwin Kwok & Hideho Okada. (2020) T-Cell based therapies for overcoming neuroanatomical and immunosuppressive challenges within the glioma microenvironment. Journal of Neuro-Oncology 147:2, pages 281-295.
Crossref
Crossref
Michael Schulz, Anna Salamero-Boix, Katja Niesel, Tijna Alekseeva & Lisa Sevenich. (2019) Microenvironmental Regulation of Tumor Progression and Therapeutic Response in Brain Metastasis. Frontiers in Immunology 10.
Crossref
Crossref
Ana Carolina Martínez-Torres, Kenny Misael Calvillo-Rodríguez, Ashanti Concepción Uscanga-Palomeque, Luis Gómez-Morales, Rodolfo Mendoza-Reveles, Diana Caballero-Hernández, Philippe Karoyan & Cristina Rodríguez-Padilla. (2019) PKHB1 Tumor Cell Lysate Induces Antitumor Immune System Stimulation and Tumor Regression in Syngeneic Mice with Tumoral T Lymphoblasts. Journal of Oncology 2019, pages 1-11.
Crossref
Crossref
Steve Swenson, Radu O. Minea, Cao Duc Tuan, Thu-Zan Thein, Thomas C. Chen & Francis S. Markland. (2018) A Novel Venom-Derived Peptide for Brachytherapy of Glioblastoma: Preclinical Studies in Mice. Molecules 23:11, pages 2918.
Crossref
Crossref